Ltb4 as vaccine adjuvant
CA 2452008 C · Owner: Ltb4 Sweden Ab · Inventors: Borgeat, Pierre; Gosselin, Jean; Flamand, Louis
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to a vaccine adjuvant for enhancing immune response of an individual to a vaccine which comprises an immune-enhancing , effective amount of an LTB4 agent in association with a pharmaceutically effective vaccine carrier.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 26, 2002 and granted March 6, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 26, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 26, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.